Weed (BUDZ) Gross Profit (2010 - 2022)
Weed (BUDZ) recorded quarterly Gross Profit of $2230.0 in Q4 2022, up 200.0% quarter-over-quarter from -$2230.0 in Q3 2022.
Weed (BUDZ) Gross Profit (2010 - 2022) Analysis & Trends
Weed's Gross Profit history runs 3 years deep, the most recent figure standing at $2230.0 for Q4 2022.
- In Q4 2022, Gross Profit changed N/A year-over-year to $2230.0; the TTM figure through Mar 2025 stood at $2230.0 (changed N/A YoY), while the FY2011 annual figure was -$12950.0, up 67.78% from the prior year.
- Gross Profit was $2230.0 for Q4 2022 at Weed, up from -$2230.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $2230.0 in Q4 2022 to a low of -$2230.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Weed | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2,230.00 |
| Dec 31, 2022 | 2,230.00 |
| Sep 30, 2022 | -2,230.00 |
| Sep 30, 2022 | -2,230.00 |
| Dec 31, 2011 | -12,950.00 |
| Dec 31, 2011 | -12,950.00 |
| Dec 31, 2010 | -40,187.00 |
| Dec 31, 2010 | -40,187.00 |
| Jun 30, 2010 | -678.00 |
| Jun 30, 2010 | -678.00 |